Generic drugmakers denied judgment on damages in Humana's US case over drug pricing
( August 19, 2026, 15:11 GMT | Official Statement) -- MLex Summary: Actavis, Teva Pharmaceuticals and other drug companies were denied a judgment to offset damages sought by Humana in a US antitrust case over generic drug prices. US District Judge Cynthia M. Rufe denied the motion because the companies’ arguments either rely on out-of-date data, present disputed material facts suited for trial, or attempt to misapply legal doctrines regarding third-party recoveries and assignments.See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.